CN102861085B - Houttuynoid E在制备治疗或预防肾纤维化的药物中的应用 - Google Patents
Houttuynoid E在制备治疗或预防肾纤维化的药物中的应用 Download PDFInfo
- Publication number
- CN102861085B CN102861085B CN 201210418716 CN201210418716A CN102861085B CN 102861085 B CN102861085 B CN 102861085B CN 201210418716 CN201210418716 CN 201210418716 CN 201210418716 A CN201210418716 A CN 201210418716A CN 102861085 B CN102861085 B CN 102861085B
- Authority
- CN
- China
- Prior art keywords
- houttuynoid
- renal fibrosis
- medicine
- treating
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 201000002793 renal fibrosis Diseases 0.000 title claims abstract description 18
- 239000003814 drug Substances 0.000 title claims abstract description 12
- VCNWTZPWIVDHGN-SLBJRTIWSA-N 2-[4,5-dihydroxy-2-(2-oxoundecyl)phenyl]-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one Chemical compound CCCCCCCCCC(=O)CC1=CC(O)=C(O)C=C1C1=C(O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 VCNWTZPWIVDHGN-SLBJRTIWSA-N 0.000 title abstract description 54
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 13
- 230000002265 prevention Effects 0.000 claims description 6
- 229930190556 houttuynoid Natural products 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 14
- 241000700159 Rattus Species 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 8
- 102000016359 Fibronectins Human genes 0.000 description 7
- 108010067306 Fibronectins Proteins 0.000 description 7
- 206010016654 Fibrosis Diseases 0.000 description 7
- 230000004761 fibrosis Effects 0.000 description 7
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 5
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 5
- 229960002591 hydroxyproline Drugs 0.000 description 5
- 238000010253 intravenous injection Methods 0.000 description 5
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 5
- 210000000626 ureter Anatomy 0.000 description 5
- 208000009889 Herpes Simplex Diseases 0.000 description 4
- 241000700584 Simplexvirus Species 0.000 description 4
- 230000003602 anti-herpes Effects 0.000 description 4
- 240000000691 Houttuynia cordata Species 0.000 description 3
- 235000013719 Houttuynia cordata Nutrition 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- XPCFTKFZXHTYIP-PMACEKPBSA-N Benazepril Chemical compound C([C@@H](C(=O)OCC)N[C@@H]1C(N(CC(O)=O)C2=CC=CC=C2CC1)=O)CC1=CC=CC=C1 XPCFTKFZXHTYIP-PMACEKPBSA-N 0.000 description 2
- 101000693993 Homo sapiens Sodium channel protein type 4 subunit alpha Proteins 0.000 description 2
- 208000007599 Hyperkalemic periodic paralysis Diseases 0.000 description 2
- 102100027195 Sodium channel protein type 4 subunit alpha Human genes 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 229960004530 benazepril Drugs 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000010970 Connexin Human genes 0.000 description 1
- 108050001175 Connexin Proteins 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 208000031816 Pathologic Dilatation Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010038540 Renal tubular necrosis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001434 glomerular Effects 0.000 description 1
- 206010061989 glomerulosclerosis Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000885 nephron Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002550 vasoactive agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210418716 CN102861085B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid E在制备治疗或预防肾纤维化的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210418716 CN102861085B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid E在制备治疗或预防肾纤维化的药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102861085A CN102861085A (zh) | 2013-01-09 |
CN102861085B true CN102861085B (zh) | 2013-07-17 |
Family
ID=47440403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210418716 Active CN102861085B (zh) | 2012-10-27 | 2012-10-27 | Houttuynoid E在制备治疗或预防肾纤维化的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102861085B (zh) |
-
2012
- 2012-10-27 CN CN 201210418716 patent/CN102861085B/zh active Active
Non-Patent Citations (2)
Title |
---|
Houttuynoids A-E, Anti-Herpes Simplex Virus Active Flavonoids with Novel Skeletons from Houttuynia cordata;Shao-Dan Chen et al;《ORGANIC LETTERS》;20120313;第14卷(第7期);1772–1775 * |
Shao-DanChenetal.HouttuynoidsA-E Anti-Herpes Simplex Virus Active Flavonoids with Novel Skeletons from Houttuynia cordata.《ORGANIC LETTERS》.2012 |
Also Published As
Publication number | Publication date |
---|---|
CN102861085A (zh) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101095668B (zh) | 迷迭香酸在制备治疗或预防肝纤维化和肾纤维化的药物中的应用 | |
CN102861085B (zh) | Houttuynoid E在制备治疗或预防肾纤维化的药物中的应用 | |
CN105287546A (zh) | Virosaines B在制备治疗和预防肾纤维化药物中的应用 | |
CN102861063B (zh) | Houttuynoid C在制备治疗或预防肾纤维化的药物中的应用 | |
CN102861072B (zh) | Houttuynoid A在制备治疗或预防肾纤维化的药物中的应用 | |
CN103251603A (zh) | Myriberine A在制备治疗和预防肾纤维化药物中的应用 | |
CN102872130B (zh) | Houttuynoid D在治疗或预防肾纤维化的药物中的应用 | |
CN103585149B (zh) | Nitrosporeusines A在治疗和预防肾纤维化药物中的应用 | |
CN107854461A (zh) | Apigenin在制备治疗和预防肾纤维化药物中的应用 | |
CN102872042B (zh) | Gypensapogenin B在制备治疗或预防肾纤维化的药物中的应用 | |
CN103127089A (zh) | Eryngiolide A在治疗或预防肾纤维化的药物中的应用 | |
CN106265691A (zh) | Friedolanostanes在制备治疗和预防肾纤维化药物中的应用 | |
CN102872083A (zh) | Houttuynoid B在治疗或预防肾纤维化的药物中的应用 | |
CN104188978A (zh) | 闭花木酮的o-(四氢吡咯基)乙基衍生物在制备治疗或预防肾纤维化药物中的应用 | |
CN105125568A (zh) | 一种治疗和预防肾纤维化药物及其应用 | |
CN105395541A (zh) | Perovskone B在制备治疗和预防肾纤维化药物中的应用 | |
CN103356569A (zh) | Sarcaboside B在治疗或预防肾纤维化的药物中的应用 | |
CN103599095B (zh) | Hippolachnin A在治疗和预防肾纤维化药物中的应用 | |
CN103356659A (zh) | Chukrasone A在治疗或预防肾纤维化的药物中的应用 | |
CN103356588A (zh) | Sarcaboside A在制备治疗或预防肾纤维化的药物中的应用 | |
CN103120677A (zh) | Aphanamixoid A在治疗或预防肾纤维化的药物中的应用 | |
CN103520181B (zh) | Phyllanthoid A在制备治疗和预防肾纤维化药物中的应用 | |
CN103585153B (zh) | Caesanines D在治疗和预防肾纤维化药物中的应用 | |
CN103381159A (zh) | Chukrasone B在治疗或预防肾纤维化的药物中的应用 | |
CN103462992B (zh) | Aphanamgrandiol A在制备治疗和预防肾纤维化药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: NANTONG SHIJIN INDUSTRY CO., LTD. Free format text: FORMER OWNER: WU JUNHUA Effective date: 20130828 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 210009 NANJING, JIANGSU PROVINCE TO: 226000 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130828 Address after: 226000 Century Avenue, Tongzhou Economic Development Zone, Jiangsu, China, No. 197, No. Patentee after: Nantong International Industrial Co.,Ltd. Address before: 210009 No. 22, Hankou Road, Gulou District, Jiangsu, Nanjing Patentee before: Wu Junhua |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170407 Address after: 226300 Nantong high tech Zone, Jiangsu province Jinqiao West Road, No. 8, No. Patentee after: JIANGSU MEIZHONG MEDICAL TECHNOLOGY Co.,Ltd. Address before: 226000 Century Avenue, Tongzhou Economic Development Zone, Jiangsu, China, No. 197, No. Patentee before: Nantong International Industrial Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20230720 Address after: 222, A2 Building, Jianghai Zhihui Park, 1188 New Century Avenue, Nantong Hi tech Industrial Development Zone, Jiangsu Province, 226000 Patentee after: Nantong San Intellectual Property Service Co.,Ltd. Address before: 226300 No.8, Jinqiao West Road, Nantong high tech Zone, Nantong City, Jiangsu Province Patentee before: JIANGSU MEIZHONG MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130109 Assignee: Jiangsu Yichuang Packaging Materials Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048413 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Jingxuan Textile Technology Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048319 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231127 Application publication date: 20130109 Assignee: Nantong Huanlian Textile Technology Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048315 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231127 Application publication date: 20130109 Assignee: Nantong Huase Space Textile Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048606 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Anergu New Material Technology Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048605 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Laiou Electronic Technology Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048604 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Yitong Intelligent Control Technology (Nantong) Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048603 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Ouchen Electronic Technology Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048602 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Laishang Electronic Technology Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048601 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Lingde Pharmaceutical Equipment Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048600 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Chujie Electronic Equipment Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048597 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Jiaerjie Labor Care Products Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048596 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: JIANGSU KANGFEITE POWER TECHNOLOGY Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048594 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Tuoerpu Surveying and Mapping Information Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048583 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong TongZhou Jinfeng Textile Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048582 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong Weiai Home Textile Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048563 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Qiju Textile Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048556 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong Juguang Trading Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048551 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong Chenghui Pharmacy Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048548 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong Tongzhou Kangxintang Drugstore Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048542 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong Tuanpinhui E-commerce Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048537 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong Koushun E-commerce Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048506 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong Tuoda Machinery Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048494 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Weizhi New Material Technology (Nantong) Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048487 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: NANTONG FEIHAI ELECTRONIC TECHNOLOGY CO.,LTD. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048483 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Haoshi new material technology Nantong Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048475 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: Nantong Steel Machinery Manufacturing Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048466 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231128 Application publication date: 20130109 Assignee: NANTONG YUQI METAL PRODUCTS Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048459 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: NANTONG KYLIN MACHINERY LTD. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048456 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: NANTONG LILIAN MACHINE TOOL MANUFACTURING CO.,LTD. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048450 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Yuma Electromechanical Manufacturing Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048446 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Dongdong Steel Structure Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048444 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Huaxin Price Evaluation Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048443 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Yaocheng mechanical equipment manufacturing Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048440 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 Application publication date: 20130109 Assignee: Nantong Xinxin Pharmaceutical Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048425 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231129 |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130109 Assignee: Nantong Yijialai Woolen Knitting Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980049377 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: NANTONG BEITE PHARMACEUTICAL MACHINERY Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980049199 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: NANTONG HAIGUO MACHINERY Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980049196 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: Nantong Qiaojiang packaging materials Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980049191 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: Nantong Bairun Catering Management Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980049185 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: Nantong Nongchaoer Food Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048976 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: Xingren Tank Farm of Nantong Xinhai Liquefied Gas Service Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048969 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: NANTONG SHUANGHE FOOD Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048967 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: Jiangsu guanan electromechanical Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048961 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: Nantong Runyuan structural parts Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048952 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231203 Application publication date: 20130109 Assignee: Nantong Jinbao Machinery Manufacturing Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048947 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231202 Application publication date: 20130109 Assignee: Nantong Juntai motor vehicle testing Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048942 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231202 Application publication date: 20130109 Assignee: Honglei mechanical equipment (Nantong) Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048782 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231202 Application publication date: 20130109 Assignee: American Antelope Home Textile (Nantong) Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048774 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231202 Application publication date: 20130109 Assignee: Nantong Ansheng Textile Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048765 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231130 Application publication date: 20130109 Assignee: NANTONG YA TAI CANDLE ARTS & CRAFTS Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048764 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231130 Application publication date: 20130109 Assignee: Nantong Jianwei Metal Technology Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048759 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231202 Application publication date: 20130109 Assignee: JIANGSU YATAI FITNESS CO.,LTD. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980048748 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231202 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130109 Assignee: Nantong Zhili Machinery Technology Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2023980049698 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20231205 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
OL01 | Intention to license declared | ||
OL01 | Intention to license declared | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130109 Assignee: JIANGSU HAOHAN INFORMATION TECHNOLOGY Co.,Ltd. Assignor: Nantong San Intellectual Property Service Co.,Ltd. Contract record no.: X2024980003183 Denomination of invention: The application of Houttuynoid E in the preparation of drugs for the treatment or prevention of renal fibrosis Granted publication date: 20130717 License type: Common License Record date: 20240322 |
|
EE01 | Entry into force of recordation of patent licensing contract |